Apolipoprotein E, statins, and risk of intracerebral hemorrhage.

Stroke

From the Departments of Neurology (D.W., M.L.F., M.H., S.R.M., L.S., B.M.K., D.O.K., C.J.M., J.P.B.), and Environmental Health (R.D.), University of Cincinnati, OH; Division of Neurocritical Care and Emergency Neurology (G.J.F., C.D.A., J.R.), and Hemorrhagic Stroke Research Group (G.J.F., S.M.G., A.M.A., C.D.A., J.R.), Department of Neurology, and Center for Human Genetic Research (G.J.F., C.D.A., J.R.), Massachusetts General Hospital, Boston; Program in Medical and Population Genetics, Broad Institute, Cambridge, MA (G.J.F., C.D.A., J.R.); Department of Biostatistical Sciences, Wake Forest University, Winston-Salem, NC (C.D.L.); and Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center, OH (J.G.W.).

Published: November 2013

Background And Purpose: Apolipoprotein E (ApoE) genotypes have been associated with lobar intracerebral hemorrhage (ICH). Although statins have been associated with an increased risk of ICH, meta-analyses have not consistently shown a statin-induced risk of ICH. Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use.

Methods: The Genetic and Environmental Risk Factors for Hemorrhagic Stroke (GERFHS) study is a prospective, demographically matched case-control study of ICH. A similar study of ICH, Genetic Risks for Medication-Related Hemorrhagic Stroke (GOCHA), was used as a replication cohort. Subjects were classified as normocholesterolemia, HC without statin use, and HC with statin use. Statistical comparisons were performed using Fisher exact test, χ2 tests, and the Breslow-Day test.

Results: The discovery cohort consisted of 558 ICH cases and 1444 controls, and the replication cohort consisted of 1020 ICH cases and 382 controls. The association of lower risk for HC was not attenuated by statin use. Statin use was observed to confer a higher risk for lobar ICH in those carrying ApoE4/E4 and ApoE2/E4 genotypes in both discovery and replication cohorts, and a test for interaction showed a trend towards significance (P=0.11 for statin and ApoE4/E4).

Conclusions: Statin use does not seem to attenuate the association of HC with decreased risk for nonlobar ICH. Our data support a gene-by-drug effect for lobar ICH, but larger sample sizes are needed to confirm the association before any clinical change is warranted.

Clinical Trial Registration Url: http://clinicaltrials.gov. Unique identifier: NCT00930280.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873717PMC
http://dx.doi.org/10.1161/STROKEAHA.113.001304DOI Listing

Publication Analysis

Top Keywords

risk ich
12
ich
11
risk
8
intracerebral hemorrhage
8
hemorrhagic stroke
8
study ich
8
replication cohort
8
statin statin
8
cohort consisted
8
ich cases
8

Similar Publications

True total-body and extended axial field-of-view (AFOV) PET/CT with 1m or more of body coverage are now commercially available and dramatically increase system sensitivity over conventional AFOV PET/CT. The Siemens Biograph Vision Quadra (Quadra), with an AFOV of 106cm, potentially allows use of significantly lower administered radiopharmaceuticals as well as reduced scan times. The aim of this study was to optimise acquisition protocols for routine clinical imaging with FDG on the Quadra the prioritisation of reduced activity given physical infrastructure constraints in our facility.

View Article and Find Full Text PDF

Global regional and national burden of intracerebral hemorrhage between 1990 and 2021.

Sci Rep

January 2025

Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Intracerebral hemorrhage (ICH) represents one of the most devastating forms of stroke, characterized by spontaneous bleeding into the brain parenchyma. This neurological emergency carries a substantial burden of mortality and long-term disability worldwide. A comprehensive understanding of ICH's evolving global impact from 1990 to 2021 remains essential for healthcare planning and resource allocation.

View Article and Find Full Text PDF

The effect of sarpogrelate compared to aspirin in high- or very-high-risk diabetes for primary prevention.

Sci Rep

January 2025

Gachon Medical Research Institute, Gachon Biomedical Convergence Institute, Gachon University Gil Medical Center, College of Medicine, Gachon University, Incheon, 21565, Republic of Korea.

The benefit of aspirin in primary prevention for atherosclerotic cardiovascular diseases (ASCVD) is questionable due to bleeding complications. We analyzed the Korean National Health Insurance data to compare the efficacy and overall bleeding of sarpogrelate, an antiplatelet agent with lower bleeding risk, versus aspirin in high-/very-high-risk diabetic populations without prior ASCVD. The primary endpoint was net adverse clinical events (NACE), defined as a composite of efficacy and overall bleeding.

View Article and Find Full Text PDF

Exploring the genetic causal inference between plasma lipidome and hemorrhagic stroke.

J Stroke Cerebrovasc Dis

January 2025

Department of Neurosurgery; The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang Province, 150001, PR China; NHC Key Laboratory of Cell Transplantation, Harbin Medical University, Harbin, China. Electronic address:

Objectives: Recent research indicates that the plasma lipidome composition may undergo alterations following hemorrhagic stroke. Nevertheless, the causal inference between plasma lipidome and hemorrhagic stroke remains elusive.

Materials And Methods: Exposure data were achieved from a recent Genome-wide Association Study (GWAS) study of 179 lipid species involving 7,174 individuals, while the outcome data were obtained from the FinnGen consortium (R10), including intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and non-traumatic intracranial hemorrhage (nITH).

View Article and Find Full Text PDF

Prevalence and determinants of ideal cardiovascular health by sex and region-a population-based study in Peru.

Front Cardiovasc Med

January 2025

Instituto de Investigación de Enfermedades Tropicales, Universidad Nacional Toribio Rodríguez de Mendoza de Amazonas (UNTRM), Amazonas, Peru.

Introduction: Attaining what the American Heart Association terms Ideal Cardiovascular Health (ICVH) is viewed as an essential objective for preventing cardiovascular diseases (CVD).

Objective: To determine the prevalence of ICVH, stratified by sex and region and its associated factors in the adult population of Peru.

Materials And Methods: Analytical cross-sectional study.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!